Showing results (111-120 of 599) with videos related to
Sort By:
Pageof 60
Pharmacopsychiatry|August 25, 2000
Epidemiological evidence for a low abuse potential of zolpidemM Soyka, R Bottlender, H J MöllerPharmacopsychiatry|March 1, 1991
Brofaromine--a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findingsH J Möller, G Wendt, P WaldmeierSchizophrenia Research|July 29, 2000
Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patientsR Bottlender, A Strauss, H J MöllerEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 20, 2002
Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidoneJ Peuskens, H J Möller, A PuechFortschritte Der Neurologie-Psychiatrie|April 8, 1998
[The effect of selective serotonin-reuptake inhibitors in blood coagulation]R Bottlender, P Dobmeier, H J MöllerPharmacopsychiatria|September 1, 1981
[Depressive states during the clinical treatment of 280 schizophrenic inpatients (author's transl)]H J Möller, D V von ZerssenPsychiatrische Praxis|July 1, 1982
[Care of patients after attempted suicide: tasks, problems and possibilities of improvement]H J Möller, A Torhorst, C WächtlerPharmacopsychiatry|November 1, 1994
Efficacy of new generation antidepressants: meta-analysis of imipramine-controlled studiesH J Möller, J Fuger, S KasperActa Psychiatrica Scandinavica|July 23, 2008
Neuroimaging genetics: new perspectives in research on major depression?T Frodl, H-J Möller, E MeisenzahlPsychiatrische Praxis|March 1, 1986
[Description of sociodemographic and psychiatric data of 295 patients following attempted suicide by poisoning--inpatient treatment within the scope of a psychiatric liaison service at an internal medicine clinic of a large municipal hospital]A Torhorst, C Wächtler, H J MöllerPageof 60